Literature DB >> 24362256

On the classification of congenital thumb hypoplasia.

M A Tonkin1.   

Abstract

In 1937, Müller introduced the concept of a teratological sequence of thumb hypoplasia with increasing severity from mild deficiency, through severe deficiency, to thumb absence. Blauth subsequently detailed five specific grades. In 1992, Manske and McCarroll altered Blauth's classification such that Grade 3 was sub-divided into Grades 3A and 3B, according to a presence or absence of the proximal metacarpal. Buck-Gramcko added a Grade 3C in which there was only a remnant metacarpal head. This article investigates their publications and those of others to identify 'who said what' and clarify the definitions of grades of thumb hypoplasia. A modification of Blauth's classification is proposed, which retains the integrity of the concept of Müller and the skeletal and soft tissue grading of Blauth, but which also incorporates the disparate anomalies that may present in Grades 2 and 3 hypoplastic thumbs.
© The Author(s) 2013.

Entities:  

Keywords:  Blauth; Manske; Thumb hypoplasia; classification

Mesh:

Year:  2013        PMID: 24362256     DOI: 10.1177/1753193413516246

Source DB:  PubMed          Journal:  J Hand Surg Eur Vol        ISSN: 0266-7681


  3 in total

Review 1.  Radiographic assessment of congenital malformations of the upper extremity.

Authors:  Matthew J Winfeld; Hansel Otero
Journal:  Pediatr Radiol       Date:  2016-06-15

2.  Reversed vascularized second metatarsal flap for reconstruction of Manske type IIIB and IV thumb hypoplasia with reduced donor site morbidity.

Authors:  De-Di Tong; Le-Hao Wu; Peng-Cheng Li; Yan-Bo Rong; Bo Liu; WPAndrew Lee; Qi-Pei Wei; Lu Liu; He-Jia Miao; Shan-Lin Chen
Journal:  Chin Med J (Engl)       Date:  2019-11-05       Impact factor: 2.628

3.  Methods for Congenital Thumb Hypoplasia Reconstruction. A Review of the Outcomes for Ten Years of Surgical Treatment.

Authors:  Dzintars Ozols; Marisa Maija Butnere; Aigars Petersons
Journal:  Medicina (Kaunas)       Date:  2019-09-20       Impact factor: 2.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.